Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
Revolutionizing Sleep Apnea Diagnosis with Wearable Technology Tackling the increasing prevalence of sleep disorders like sleep apnea, Georgia Tech researchers have brought a paradigm shift in the field of sleep diagnostics. Their development of a wearable sleep monitor patch, characterized by its accuracy and comfort, offers the promise of a more accessible and cost-effective means of diagnosing sleep disorders, revolutionizing the way sleep medicine is practiced.
Cardiology June 6th 2023
Addiction Professional
Opvee Reverses Remifentail-induced Respiratory Depression Within 5 Minutes As the opioid crisis continues to evolve, so too does your arsenal of interventions. The FDA’s recent approval of Opvee, a nalmefene-based nasal spray, introduces a new tool for physicians in the fight against opioid overdose.
Clinical Pharmacology June 6th 2023
ReachMD
Understanding COVID-19’s Cognitive Effects on College Students As physicians, understanding the cognitive effects of the COVID-19 pandemic on our younger population is crucial. This summary distills key findings from a recent study conducted by The Ohio State University.
Family Medicine/General Practice June 6th 2023
Psychiatrist.com
Understanding the Effects of Drugs with Depressive Symptom Side Effects on Patients with MDD Learn more about the complex interaction between the usage of specific drugs and the severity of depressive symptoms in people with major depressive disorder (MDD).
Psychiatry June 6th 2023
Journal of Neurology, Neurosurgery & Psychiatry
Dopaminergic Dysfunction: A Key Player in Parkinson’s Disease Motivational Symptoms This study reveals a significant link between dopaminergic dysfunction and the emergence of motivational symptoms in Parkinson’s disease. Striatal DAT imaging emerges as a potential tool for predicting apathy/anhedonia risk, opening new avenues for intervention strategies.
Neurology June 6th 2023
The New England Journal of Medicine
Decoding the Efficacy: Ketamine and ECT in the Battle Against Treatment-Resistant Depression As you delve into the comparative effectiveness of ketamine and ECT, NEJM highlights the key findings from a recent noninferiority trial that could reshape your understanding of these treatments.